Literature DB >> 14574054

Use of BNP levels in monitoring hospitalized heart failure patients with heart failure.

Alan S Maisel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14574054     DOI： 10.1023/a:1026139130208

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  11 in total

1.  Algorithms for using B-type natriuretic peptide levels in the diagnosis and management of congestive heart failure.

Authors:  Alan Maisel
Journal:  Crit Pathw Cardiol       Date:  2002-06

2.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

Authors: 
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

3.  Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

Authors:  W T Abraham; B D Lowes; D A Ferguson; J Odom; J K Kim; A D Robertson; M R Bristow; R W Schrier
Journal:  J Card Fail       Date:  1998-03       Impact factor: 5.712

4.  Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.

Authors:  R Sodian; M Loebe; C Schmitt; E V Potapov; H Siniawski; J Müller; H Hausmann; H R Zurbruegg; Y Weng; R Hetzer
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

Review 5.  Pharmacologic therapies for acutely decompensated heart failure.

Authors:  Gregg C Fonarow
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

Review 6.  Safety and efficacy of nesiritide for the treatment of decompensated heart failure.

Authors:  Charles L Emerman
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

7.  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

Authors:  R Kazanegra; V Cheng; A Garcia; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal:  J Card Fail       Date:  2001-03       Impact factor: 5.712

8.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

Authors:  V Cheng; R Kazanagra; A Garcia; L Lenert; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

9.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries.

Authors:  H M Krumholz; E M Parent; N Tu; V Vaccarino; Y Wang; M J Radford; J Hennen
Journal:  Arch Intern Med       Date:  1997-01-13

10.  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.

Authors:  Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690
View more
  1 in total

1.  In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.

Authors:  Salvatore Di Somma; Laura Magrini; Valerio Pittoni; Rossella Marino; Antonella Mastrantuono; Enrico Ferri; Paola Ballarino; Andrea Semplicini; Giuliano Bertazzoni; Giuseppe Carpinteri; Paolo Mulè; Maria Pazzaglia; Kevin Shah; Alan Maisel; Paul Clopton
Journal:  Crit Care       Date:  2010-06-16       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.